135 related articles for article (PubMed ID: 3671911)
21. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
22. [Application of flow cytometry to the diagnosis of bladder carcinoma].
Matsuura T
Hinyokika Kiyo; 1986 Dec; 32(12):1917-24. PubMed ID: 2435136
[TBL] [Abstract][Full Text] [Related]
23. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study.
Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K; Bacus JW
Diagn Cytopathol; 1995 Oct; 13(3):214-23; discussion 224. PubMed ID: 8575280
[TBL] [Abstract][Full Text] [Related]
24. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.
van der Heijden AG; Kiemeney LA; Gofrit ON; Nativ O; Sidi A; Leib Z; Colombo R; Naspro R; Pavone M; Baniel J; Hasner F; Witjes JA
Eur Urol; 2004 Jul; 46(1):65-71; discussion 71-2. PubMed ID: 15183549
[TBL] [Abstract][Full Text] [Related]
25. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.
Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K
Anal Quant Cytol Histol; 1994 Feb; 16(1):1-10. PubMed ID: 8011035
[TBL] [Abstract][Full Text] [Related]
26. [Flow cytometry in bladder lavage fluid for the diagnosis and surveillance of bladder tumors. Preliminary results].
Rossi D; de Fromont M; Serment G; Rampal M
Prog Urol; 1992; 2(4):604-15. PubMed ID: 1302100
[TBL] [Abstract][Full Text] [Related]
27. Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladder.
Melissourgos ND; Kastrinakis NG; Skolarikos A; Pappa M; Vassilakis G; Gorgoulis VG; Salla C
Urology; 2005 Sep; 66(3):536-41. PubMed ID: 16140073
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
[TBL] [Abstract][Full Text] [Related]
29. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
Pham HT; Soloway MS
Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
[TBL] [Abstract][Full Text] [Related]
30. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of DNA content as measured by flow cytometry and image analysis in 1864 specimens.
Bertino B; Knape WA; Pytlinska M; Strauss K; Hammou JC
Anal Cell Pathol; 1994 May; 6(4):377-94. PubMed ID: 8060892
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
33. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
[TBL] [Abstract][Full Text] [Related]
34. Characterization of bladder papilloma by two-parameter DNA-RNA flow cytometry.
Klein FA; Melamed MR; Whitmore WF; Herr HW; Sogani PC; Darzynkiewicz Z
Cancer Res; 1982 Mar; 42(3):1094-7. PubMed ID: 6174212
[TBL] [Abstract][Full Text] [Related]
35. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
37. [Clinical application of flow cytometry in urology. 2. Comparison between bladder biopsy specimens and bladder irrigation samples by flow cytometric DNA-histogram].
Tachibana M; Nakamura S; Shibayama T; Jitsukawa S; Deguchi N; Baba S; Nakazono M; Hata M; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1986 Nov; 77(11):1857-63. PubMed ID: 3573469
[No Abstract] [Full Text] [Related]
38. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
Nenning H; Rassler J; Minh DH; Stolzenburg JU
Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
[TBL] [Abstract][Full Text] [Related]
39. Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor.
Casella R; Huber P; Blöchlinger A; Stoffel F; Dalquen P; Gasser TC; Lehmann K
J Urol; 2000 Dec; 164(6):1926-8. PubMed ID: 11061883
[TBL] [Abstract][Full Text] [Related]
40. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
